Table 3.

GO and KEGG pathway enrichment of miRNA targets in poorly differentiated HCC. FDR, false discovery rate

	GO ID	Item	No.	FDR
GO enrichment	GO:0006631	Fatty acid metabolic process	20	8.71 × 10−13
	GO:0008206	Bile acid metabolic process	14	1.68 × 10−11
	GO:0006629	Lipid metabolic process	31	2.46 × 10−11
	GO:0006699	Bile acid biosynthetic process	11	1.08 × 10−10
	GO:0007586	Digestion	12	9.67 × 10−7
	GO:0015721	Bile acid and bile salt transport	7	2.38 × 10−6
	GO:0001889	Liver development	11	1.13 × 10−4
	GO:0030573	Bile acid catabolic process	3	5.07 × 10−4
Pathway enrichment	hsa04110	Cell cycle	28	1.11 × 10−16
	hsa03320	PPAR signaling pathway	19	3.83 × 10−13
	hsa00071	Fatty acid metabolism	15	1.45 × 10−12
	hsa00120	Primary bile acid biosynthesis	9	7.61 × 10−10
	hsa04976	Bile secretion	14	3.56 × 10−8
	hsa04920	Adipocytokine signaling pathway	9	2.59 × 10−4
	hsa04115	p53 signaling pathway	9	2.59 × 10−4
	hsa05200	Pathways in cancer	21	4.8 × 10−4
	hsa04975	Fat digestion and absorption	6	2.537 × 10−3
	hsa04010	MAPK signaling pathway	14	2.0704 × 10−2